Moderately bullish activity in Moderna (MRNA), with shares up 96c, or 3.11%, near $31.82. Options volume running well above average with 111k contracts traded and calls leading puts for a put/call ratio of 0.94, compared to a typical level near 0.66. Implied volatility (IV30) is higher by 1.2 points near 61.2,in the bottom quartile of the past year, suggesting an expected daily move of $1.23. Put-call skew steepened, indicating increased demand for downside protection.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna Highlights 2025 Progress and Strengthened Vaccine Portfolio
- Moderna announces regulatory submissions for seasonal influenza vaccine
- Moderna announces global regulatory submissions for seasonal influenza vaccine
- Mixed options sentiment in Moderna with shares down 0.64%
- SPY ETF Daily Update, 12/23/2025